Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000885590-12-000010)

Filing Details

Accession Number:: 0000885590-12-000010
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-05 17:18:13
Reporting Period:: 2012-03-01

Filing Date:: 2012-03-05
Accepted Time:: 2012-03-05 17:18:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1536053	Bradley Howard Schiller	7150 Mississauga Road Mississauga A6 L5N 8M5	Evp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Acquisiton	2012-03-01	9,300	$53.47	118,300	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2012-03-02	9,300	$53.81	127,600	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Represents the weighted average purchase price. Purchases were made in the range of $51.13 to $54.18.
This number includes common shares purchased by the officer and restricted share units that were previously reported in Table 1.
Represents the weighted average purchase price. Purchases were made in the range of $53.64 to $53.94.